Novavax COVID-19 vaccine now available
Effective April 11, 2022, the Novavax COVID-19 vaccine became available in limited quantities in Saskatchewan.
The Novavax COVID-19 vaccine:
- Is available to residents 18 years and older;
- requires two doses, at least 21 days apart;
- is available for third/fourth doses;
- is only available in limited quantities at select SHA walk-in clinics, or;
- can be booked in advance by calling 1-833-SASKVAX (727-5829).
Novavax is a protein-based vaccine – a well-known and safe technology that has been in use for decades, and is used in many hepatitis and influenza vaccines.
This vaccine contains a protein that is found on the surface of the COVID-19 virus and an adjuvant, which is a substance to boost your immune response, called Matrix-M. While mRNA (Pfizer, Moderna) and Viral Vector (AstraZeneca, Johnson and Johnson) vaccines tell your body how to create proteins found on the COVID-19 virus that trigger your immune system to respond, protein-based vaccines like Novavax have purified proteins present already which trigger our immune system to create antibodies that help protect us against serious illness and death.
Clinical trials of the vaccine showed that Novavax prevented serious illness from COVID-19 90 per cent of the time.
For more information on Novavax and other available COVID-19 vaccines, and to book an appointment, visit Saskatchewan.ca/covid19-vaccine.
